| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Alpha-1-Antitrypsin Pi*MZ variant increases risk of developing hepatic events in nonalcoholic fatty liver disease patients,
|
Murali, Arvind R.
|
|
|
47 |
2 |
p.
|
article
|
| 2 |
Clinical application study on miR-98–5p as a prognostic biomarker in hepatocellular carcinoma
|
Ji, Peng-tian
|
|
|
47 |
2 |
p.
|
article
|
| 3 |
Contents
|
|
|
|
47 |
2 |
p.
|
article
|
| 4 |
Drug-induced hepatitis (DIH) after SARS-CoV-2 vaccination
|
Asgarzdeh, Ali
|
|
|
47 |
2 |
p.
|
article
|
| 5 |
Editorial board
|
|
|
|
47 |
2 |
p.
|
article
|
| 6 |
Efficacy and safety of HER2-targeted therapy in patients with colorectal cancer: What should we expect from a meta-analysis?
|
Wang, Menglei
|
|
|
47 |
2 |
p.
|
article
|
| 7 |
Screening and management of portal hypertension in advanced hepatocellular carcinoma: A French practice survey
|
Allaire, Manon
|
|
|
47 |
2 |
p.
|
article
|
| 8 |
The detection rate of granulomas differs between intestinal segments and lesions in Chinese patients with Crohn's disease
|
Chen, Lin-Teng
|
|
|
47 |
2 |
p.
|
article
|
| 9 |
T lymphocyte-mediated pyroptosis: A new regulatory mechanism in non-viral liver disease
|
Xiong, Wanyuan
|
|
|
47 |
2 |
p.
|
article
|
| 10 |
Transarterial chemoembolization failure in patients with hepatocellular carcinoma: Incidence, manifestation and risk factors
|
Zhang, Lijie
|
|
|
47 |
2 |
p.
|
article
|
Journal description